{"title":"[Relationship between the prognosis of interstitial pneumonia and its comorbidities].","authors":"Katsutoshi Ando, Yoshihiro Ohkuni, Hideki Makino, Yasutaka Kawamura, Shinji Motojima, Norihiro Kaneko","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To investigate the relationship between the prognosis of chronic interstitial pneumonia (IP) and its comorbidities, we conducted a retrospective study for clinically and radiologically diagnosed IP. We assessed comorbidities by using the Charlson Comorbidity Index (CCI).</p><p><strong>Methods: </strong>We classified 224 patients given clinical diagnoses of chronic IP (excluding the patients who had clear causes such as collagen disease, infection, drugs or radiation) in our institution between April 2000 and June 2010, into 2 groups; those with clinical diagnoses of idiopathic pulmonary fibrosis (IPF:108 cases) and those with other chronic IP but without honeycomb lung (116 cases); and analyzed their backgrounds and comorbidities. We also classified them into survival and non-survival groups to assess their prognostic factors.</p><p><strong>Results: </strong>Although the smoking status of patients with clinically diagnosed IPF was higher, and SpO2 was lower than those with other chronic IP without honeycomb lung, the mean age, comorbidities and CCI did not differ between them. The 5-year overall survival of the clinically-diagnosed IPF group was lower than that of the other chronic IP without honeycomb lung group (50.8% vs. 76.3%, p<0.01). In cases of other chronic IP without honeycomb lung, the CCI of non-survival cases was higher than that of survival cases (4.05 vs. 2.47, p<0.01), although patient backgrounds did not differ between survival and non-survival cases in those with clinically diagnosed IPF (CCI : 2.32 vs. 2.98, p = 0.70).</p><p><strong>Conclusions: </strong>Our analysis revealed the possibility that comorbidities and CCI were prognostic factors in other chronic IP cases without honeycomb lung, although the prognosis of IPF was not affected by their comorbidity.</p>","PeriodicalId":19218,"journal":{"name":"Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society","volume":"49 11","pages":"800-9"},"PeriodicalIF":0.0000,"publicationDate":"2011-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: To investigate the relationship between the prognosis of chronic interstitial pneumonia (IP) and its comorbidities, we conducted a retrospective study for clinically and radiologically diagnosed IP. We assessed comorbidities by using the Charlson Comorbidity Index (CCI).
Methods: We classified 224 patients given clinical diagnoses of chronic IP (excluding the patients who had clear causes such as collagen disease, infection, drugs or radiation) in our institution between April 2000 and June 2010, into 2 groups; those with clinical diagnoses of idiopathic pulmonary fibrosis (IPF:108 cases) and those with other chronic IP but without honeycomb lung (116 cases); and analyzed their backgrounds and comorbidities. We also classified them into survival and non-survival groups to assess their prognostic factors.
Results: Although the smoking status of patients with clinically diagnosed IPF was higher, and SpO2 was lower than those with other chronic IP without honeycomb lung, the mean age, comorbidities and CCI did not differ between them. The 5-year overall survival of the clinically-diagnosed IPF group was lower than that of the other chronic IP without honeycomb lung group (50.8% vs. 76.3%, p<0.01). In cases of other chronic IP without honeycomb lung, the CCI of non-survival cases was higher than that of survival cases (4.05 vs. 2.47, p<0.01), although patient backgrounds did not differ between survival and non-survival cases in those with clinically diagnosed IPF (CCI : 2.32 vs. 2.98, p = 0.70).
Conclusions: Our analysis revealed the possibility that comorbidities and CCI were prognostic factors in other chronic IP cases without honeycomb lung, although the prognosis of IPF was not affected by their comorbidity.
背景:为了探讨慢性间质性肺炎(IP)的预后与其合并症的关系,我们对临床和影像学诊断的IP进行了回顾性研究。我们使用Charlson共病指数(CCI)评估合并症。方法:将我院2000年4月至2010年6月临床诊断为慢性IP的224例患者(不包括胶原蛋白疾病、感染、药物或放疗等明确病因的患者)分为2组;临床诊断为特发性肺纤维化(IPF:108例)和其他慢性肺纤维化但无蜂窝肺(116例);并分析其背景及合并症。我们还将他们分为生存组和非生存组,以评估他们的预后因素。结果:虽然临床诊断为IPF的患者吸烟状况较高,SpO2低于其他非蜂窝肺慢性IP患者,但其平均年龄、合并症及CCI差异无统计学意义。临床诊断为IPF组的5年总生存率低于其他慢性IP无蜂窝肺组(50.8% vs. 76.3%)。结论:我们的分析揭示了合并症和CCI可能是其他慢性IP无蜂窝肺病例的预后因素,尽管IPF的预后不受其合并症的影响。